Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PARSACLISIB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where PARSACLISIB was used for B-cell lymphoma.

Most Reported Side Effects for PARSACLISIB

Side Effect Reports % Deaths Hosp.
Off label use 23 31.1% 1 8
Disease progression 15 20.3% 1 1
Pyrexia 14 18.9% 0 10
Pneumonia 11 14.9% 0 9
Bronchitis 9 12.2% 0 9
Neutropenic sepsis 9 12.2% 0 9
Neutrophil count decreased 9 12.2% 0 9
Blood lactate dehydrogenase increased 8 10.8% 0 1
Neutropenia 8 10.8% 1 2
Hypokalaemia 7 9.5% 0 7
Enterococcal bacteraemia 6 8.1% 0 0
Intentional product use issue 6 8.1% 0 6
Thrombocytopenia 6 8.1% 0 0
Acute kidney injury 5 6.8% 1 4
Alanine aminotransferase increased 5 6.8% 1 0

Other Indications for PARSACLISIB

Diffuse large b-cell lymphoma (24) Mantle cell lymphoma (11) Follicular lymphoma (7) Product used for unknown indication (5)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

PARSACLISIB Full Profile All B-cell lymphoma Drugs PARSACLISIB Demographics PARSACLISIB Timeline